James P. Madigan
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics 4
- Protein Kinase Regulation and GTPase Signaling 3
- Sphingolipid Metabolism and Signaling 3
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 6
- Cell Biology top 5%
- Aging top 10%
-
- Neuroendocrine Tumor Research Advances 5
-
- Neuroblastoma Research and Treatments 4
-
- Lymphoma Diagnosis and Treatment 4
-
- Management of metastatic bone disease 3
- Co-authors
- Adrienne D. CoxChanning J. DerMichael M. GottesmanDaniel W. RosenbergMatthew D. HallJames J. FiordalisiIan S. GoldlustJohn R. Lloyd
- Journals
- Journal of Biological Chemistry (4 papers)Molecular Cancer Therapeutics (2 papers)Cancer (2 papers)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
James P. Madigan
44 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 1.4k
- Oncology 550
- Cell Biology 230
- Aging 23
- Cancer Research 130
Countries citing papers authored by James P. Madigan
This map shows the geographic impact of James P. Madigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Madigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Madigan more than expected).
Fields of papers citing papers by James P. Madigan
This network shows the impact of papers produced by James P. Madigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Madigan. The network helps show where James P. Madigan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James P. Madigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 6 | |
| 4 | 2020 | 26 | |
| 5 | 2019 | 9 | |
| 6 | 2018 | 13 | |
| 7 | 2016 | 145 | |
| 8 | 2016 | 8 | |
| 9 | 2015 | 27 | |
| 10 | 2014 | 293 | |
| 11 | 2014 | 39 | |
| 12 | 2013 | 34 | |
| 13 | 2011 | 17 | |
| 14 | 2010 | 111 | |
| 15 | 2008 | 253 | |
| 16 | 1967 | 2 | |
| 17 | 1963 | 11 | |
| 18 | 1963 | 2 | |
| 19 | A PRELIMINARY CLINICAL REPORT CONCERNING OXYGEN BAROTHERAPY AND MEGAVOLTAGE RADIOTHERAPY | 1962 | 10 |
| 20 | 1962 | 13 |
About James P. Madigan
James P. Madigan is a scholar working on Oncology, Pathology and Forensic Medicine and Neurology, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Genomics and Chromatin Dynamics (4 papers), Neuroblastoma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Management of metastatic bone disease (3 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Oncology (550 citations) and Cell Biology (230 citations). James P. Madigan has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Adrienne D. Cox, Channing J. Der, Michael M. Gottesman, Daniel W. Rosenberg, Matthew D. Hall, James J. Fiordalisi, Ian S. Goldlust, John R. Lloyd, Tobie D. Lee and James D. Hoeschele. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cancer Therapeutics, Cancer, Carcinogenesis and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.